Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000257735 is a human non-coding RNA transcript, also known as AC090115.1, identified as an antisense RNA overlapping the ZNF641 gene. "Antisense" indicates that its RNA sequence is complementary to the messenger RNA (mRNA) of ZNF641 and may be involved in the regulation of that gene's expression through mechanisms such as RNA interference or transcriptional interference, though no specific function or therapeutic relevance has been described for this transcript in the literature to date. It is not a protein-coding gene, nor is it currently recognized as a receptor, enzyme, transporter, or any classical therapeutic target. There is no evidence supporting a role in disease, as a drug target, or as a biomarker[1][7]. Clarifications and limitations: - This entity is *not* a classical therapeutic target (such as a receptor, transporter, enzyme, or transcription factor). - It is a locus for a non-coding (antisense) RNA, with no known biological, pathological, or pharmacological role[1][7]. - Its entry as a “target” is likely incorrect or a mislabeling, as there is no evidence that it serves as a molecular target for drugs or as a marker in any disease setting. - No structured data on function, role, clinical relevance, or drug interaction is available for this locus. Summary: ENSG00000257735 (novel transcript, antisense to ZNF641/AC090115.1) is a non-coding RNA, without a known biological function, disease association, or drug interaction, and should *not* be considered a therapeutic target[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to ZNF641 (AC090115.1).